Guest
With Dr. Vibeke Manniche, MD PhD. Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine (2023). This research from Denmark work is only funded by crowd funding, via this link, Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden 2023, Nationwide study from Denmark Identified a batch-dependent safety signal for the BNT162b2 mRNA COVID-19 vaccine 2024, Suspected adverse events (SAEs) Denmark and Sweden SAEs reported to national authorities
